Why the study?
Does point-of-care D-dimer testing provide comparable laboratory performance to routine centralized laboratory assays for the exclusion of VTE?
Does point-of-care D-dimer testing provide comparable laboratory performance to routine centralized laboratory assays for the exclusion of VTE?
Point-of-care D-dimer testing offers a rapid and reliable alternative to centralized laboratory assays for excluding VTE in primary care and emergency settings.
POC D-dimer assays may enable faster VTE exclusion in primary care; leaves open prospective outcome validation before practice change.
»Point-of-Care« D-Dimer Testing D-dimer testing is efficient in the exclusion of venous thromboembolism (VTE). D-dimer laboratory assays are predominantly performed in centralised laboratories in intra-hospital settings although most patients with suspected VTE are presented in primary care. On the other hand decreasing turnaround time for laboratory testing may significantly improve efficacy in emergency departments. Therefore an introduction of a rapid, easy to perform point of care (POC) assay for the identification of D-dimer may offer improvement in diagnostics flow of VTE both in primary care and emergency departments while it could also improve our diagnostic possibilities in some other severe clinical conditions (e.g. disseminated intra-vascular coagulation (DIC) and aortic aneurism (AA)) associated with increased D-dimer. Several POC D-dimer assays have been evaluated and majority of them have met the criteria for rapid and safe exclusion of VTE. In our hands three assays (Stratus, Pathfast and Cardiac) have the laboratory performance profile comparable with our routine D-dimer laboratory assay (Tinaqaunt).
No takes yet. Share an insight, caveat, or question.
Jovan P. Antović (2010) studied this question.